BETHLEHEM, PA and SAN DIEGO -- B. Braun Medical Inc. and
Venetec International today announced a landmark agreement to jointly market
and sell a revolutionary sharps safety system combining the B. Braun
Introcan Safetyr IV Catheter and Venetec StatLockr IV catheter securement
device to reduce the risk of accidental needlestick injuries and exposure to
Under the two-year agreement, effective immediately, B. Braun will offer its
safety-conscious customers the passive-design Introcan Safety IV Catheter,
with built-in securement through Venetec's innovative StatLock IV catheter
securement device for Introcan Safety IV Catheter. The two companies have
closely collaborated to create a peripheral vascular-access system that
offers unparalleled patient safety through:
1. The StatLock securement device's improved clinical outcomes
2. Introcan Safety IV Catheter's passive design needlestick injury
3. Conformity to international color-coding for patient safety,
identifying a venous access device.
"This agreement represents a major achievement in establishing the new
worldwide standard for peripheral IV catheter safety, benefiting patients
and clinicians alike," said Steve Bierman, M.D., medical director and CEO of
Venetec International. "A passive safety catheter (Introcan Safety) with
built-in StatLock securement provides a system that is not only the easiest
to use for clinicians, but also the safest for patients and caregivers. A
new standard of care has been established."
"This partnership with Venetec International enhances our ability to offer
technology that improves patient care while protecting healthcare workers
from accidental needlestick injuries," said Caroll H. Neubauer, chairman and
CEO of B. Braun Medical. "The passive design of the
Introcan Safety IV Catheter, partnered with the custom-designed StatLock IV
catheter securement device for the Introcan Safety IV Catheter, is a unique
combination developed specifically to reduce the risk of exposure to
dangerous bloodborne pathogens."
The passive Introcan Safety IV Catheter is designed to minimize accidental
needlesticks without requiring user activation of the safety mechanism. The
passive design eliminates risk of inadvertent activation, yet the removable
flash-plug and convenient syringe attachment allow the clinician to utilize
the Introcan Safety IV Catheter much like a non-safety IV catheter design.
Compliance is virtually assured without changing technique since the safety
mechanism cannot be bypassed.
StatLock IV catheter securement device for Introcan Safety IV Catheter is
the first peripheral IV securement device to be custom-crafted so it locks
onto the catheter hub - preventing accidental dislodgements and
movement-related complications. The device is also color-coded blue,
signaling a venous access device, to further reduce medical errors.
StatLock IV catheter securement device is proven to reduce patient
complications such as phlebitis and infiltration. Much easier and faster
than tape securement, the StatLock IV catheter securement device also
reduces unscheduled catheter restarts saving hospital nursing staff time
that is now wasted on troubleshooting and restarting tape-secured IVs.
B. Braun and Venetec are members of the National Alliance for the Primary
Prevention of Sharps Injuries (NAPPSI), a nonprofit organization dedicated
to needlestick safety that includes more than 25 corporate members, more
than 1,000 individual clinicians, and major clinician professional
organizations. This collaboration in design, sales, and marketing reflects
NAPPSI's call to manufacturers to work together to maximize safety
protections for nurses and doctors.
This current agreement represents an approximately $20 million, two-year
commitment from B. Braun to Venetec. Under agreements announced last year,
B. Braun also includes the StatLock IV securement device with the B. Braun
ULTRASITEr Needle-Free IV System and includes Venetec's StatLock CV Plus
catheter securement device in B. Braun's Certofixr Central Venous Catheter